CelLBxHealth plc Stock
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.275 GBX | 0.00% |
|
-5.56% | +15.91% |
| 07-15 | Beeks in "strong" year; Iofina output up | AN |
| 07-15 | CelLBxHealth plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 14.49M 19.38M 16.98M 15.77M 27.3M 1.87B 27.7M 188M 73.52M 915M 72.77M 71.2M 3.16B | P/E 2026 * |
-0.55x | P/E 2027 * | -14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 12.89M 17.24M 15.11M 14.03M 24.29M 1.66B 24.64M 167M 65.4M 814M 64.73M 63.34M 2.81B | EV / Sales 2026 * |
0.6x | EV / Sales 2027 * | 0.42x |
| Free-Float |
94.31% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CelLBxHealth plc
| 16/10/25 | Angle names Peter Collins as interim CEO | AN |
| 28/05/25 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 23/01/25 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 14/09/23 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 24/01/22 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 week | -5.56% | ||
| Current month | -16.39% | ||
| 1 month | -8.93% | ||
| 3 months | +30.77% | ||
| 6 months | +18.60% | ||
| Current year | +15.91% |
| 1 week | 1.2 |  | 1.4 |
| 1 month | 1.2 | | 1.67 |
| Current year | 0.85 | | 2.8 |
| 1 year | 0.85 | | 8 |
| 3 years | 0.85 | | 37.4 |
| 5 years | 0.85 | | 163.75 |
| 10 years | 0.85 | | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 01/01/1999 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2025 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 22/05/2023 |
Klaas de Boer
BRD | Director/Board Member | 61 | 12/01/2026 |
| Director/Board Member | 61 | 12/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% | ||
| 19/12/25 | Buy | Chairman | 5,000,000 | 1.5497% | ||
| 19/12/25 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -5.56% | -77.83% | -92.27% | 19.38M | |
| +1.89% | -10.55% | +15.59% | -38.32% | 15.47B | |
| +1.96% | -0.64% | +4.02% | +95.77% | 1.59B | |
| -1.03% | -10.86% | -36.37% | -81.60% | 1.12B | |
| +0.86% | -1.12% | -34.39% | +18.38% | 1B | |
| -0.66% | -1.86% | -31.07% | -54.19% | 631M | |
| -2.23% | -9.52% | -46.52% | -57.97% | 516M | |
| -0.19% | -0.88% | +41.09% | -53.80% | 452M | |
| -1.61% | -3.32% | -54.58% | -60.97% | 378M | |
| -1.80% | +5.02% | -17.61% | -38.31% | 356M | |
| Average | -0.19% | -4.43% | -23.77% | -36.33% | 2.15B | |
| Weighted average by Cap. | +1.39% | -10.46% | +5.52% | -29.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.65M 28.96M 25.38M 23.56M 40.8M 2.79B 41.4M 281M 110M 1.37B 109M 106M 4.72B | 37.75M 50.5M 44.25M 41.08M 71.13M 4.87B 72.18M 489M 192M 2.38B 190M 186M 8.24B |
| Net income | -8.55M -11.44M -10.02M -9.3M -16.11M -1.1B -16.35M -111M -43.38M -540M -42.94M -42.01M -1.87B | -1.85M -2.48M -2.17M -2.01M -3.49M -239M -3.54M -23.98M -9.39M -117M -9.29M -9.09M -404M |
| Net Debt | -1.6M -2.14M -1.88M -1.74M -3.01M -207M -3.06M -20.74M -8.12M -101M -8.04M -7.86M -349M | 1.4M 1.87M 1.64M 1.52M 2.64M 181M 2.68M 18.15M 7.1M 88.44M 7.03M 6.88M 306M |
Employees
114
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | GBX 1.275 | 0.00% | 346,152 |
| 21/07/26 | GBX 1.275 | +2.00% | 512,783 |
| 20/07/26 | GBX 1.250 | 0.00% | 384,599 |
| 17/07/26 | GBX 1.250 | 0.00% | 894,293 |
| 16/07/26 | GBX 1.250 | -7.41% | 2,055,445 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0128GBP
Average target price
0.0400GBP
Spread / Average Target
+213.73%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Select your edition
All financial news and data tailored to specific country editions
